SBIR/STTR Research Award
DOD DHA SBIR Psoralen-UV-A Irradiation Based High-throughput Pathogen Inactivation Device
Award amount
$1,299,935Program and phase
SBIR · Phase IIAward year
2025Award details
- Awarding agency
- Department of Defense
- Branch
- Defense Health Agency
- Recipient company
- ADVANCED COOLING TECHNOLOGIES INC
- Proposal award date
- 2025-07-02
- Contract end date
- 2027-11-01
- UEI
- Z8KVZV3DR7J4
- Solicitation number
- 24.1
- Topic code
- DHA241-001
Research abstract
Advanced Cooling Technologies aims to develop a UV-A Reactor that inactivates pathogens at a wide range of volumes (10 mL – 50 L) with adjustable process time by tuning the fluid flow rate and UV intensity. The system is a robust and user-friendly platform with a high degree of controllability and repeatability over the inactivation process, providing a novel platform for rapid vaccine development to produce the GMP product. The project aims to develop a commercial UV-A reactor system that conducts a high throughput of psoralen/UV-A inactivation within the vaccine manufacturer's and FDA's technical requirements for making the GMP product.
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- DOD Navy SBIR Icephobic Coating for Air Cycle Machine
- Direct Etched Silicon Wafer Bonding for Micro-Electromechanical Systems (MEMS).
- Variable Emissivity Thermal Control Capability Development for Space based Applications
- Freeze Tolerant Water Heat Pipe and Thermal Switch
- Manufacturing and Measurements of 3D-Printed Porous Structures
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- VacciRAPTOR: High-throughput, Continuous Flow-Through System for Psoralen-UVA Inactivation
- Psoralen-UV-A Inactivation Based High-throughput Pathogen Inactivation Device
- Psoralen-UV-A Inactivation Based High-throughput Pathogen Inactivation Device
- VacciRAPTOR: High-throughput, Continuous Flow-through Device for Psoralen-UVA Inactivation of Dengue Virus
- Psoralen-UV-A Irradiation Based High-throughput Pathogen Inactivation Device
Research funding history
282 SBIR/STTR records share this UEI (2003–2026). Reported award amounts total $118,415,811. Reported amounts are not federal obligations.
Phases: Phase I, Phase II, Phase II – Direct to Phase II
Agencies: Department of Defense, National Aeronautics and Space Administration, Department of Energy, National Science Foundation, Department of Agriculture, Department of Health and Human Services